Pacific Net Debt from 2010 to 2026
| PACB Stock | USD 1.78 0.06 3.26% |
Net Debt | First Reported 2009-12-31 | Previous Quarter 644.4 M | Current Value 646.6 M | Quarterly Volatility 318 M |
Check Pacific Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacific Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 64.4 M, Interest Expense of 16.2 M or Total Revenue of 186 M, as well as many indicators such as Price To Sales Ratio of 3.56, Dividend Yield of 0.0 or PTB Ratio of 0.85. Pacific financial statements analysis is a perfect complement when working with Pacific Biosciences Valuation or Volatility modules.
Pacific | Net Debt | Build AI portfolio with Pacific Stock |
Analyzing Pacific Biosciences's Net Debt over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Debt has evolved provides context for assessing Pacific Biosciences's current valuation and future prospects.
Latest Pacific Biosciences' Net Debt Growth Pattern
Below is the plot of the Net Debt of Pacific Biosciences of over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Pacific Biosciences' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacific Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Pacific Net Debt Regression Statistics
| Arithmetic Mean | 212,075,375 | |
| Geometric Mean | 72,117,198 | |
| Coefficient Of Variation | 162.40 | |
| Mean Deviation | 314,280,133 | |
| Median | (4,185,000) | |
| Standard Deviation | 344,412,460 | |
| Sample Variance | 118619.9T | |
| Range | 831.2M | |
| R-Value | 0.86 | |
| Mean Square Error | 32440.2T | |
| R-Squared | 0.74 | |
| Slope | 58,814,180 | |
| Total Sum of Squares | 1897919.1T |
Pacific Net Debt History
Other Fundumenentals of Pacific Biosciences
Pacific Biosciences Net Debt component correlations
Click cells to compare fundamentals
About Pacific Biosciences Financial Statements
Pacific Biosciences stakeholders use historical fundamental indicators, such as Pacific Biosciences' Net Debt, to determine how well the company is positioned to perform in the future. Although Pacific Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pacific Biosciences' assets and liabilities are reflected in the revenues and expenses on Pacific Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pacific Biosciences of. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt | 709.6 M | 745.1 M | |
| Net Debt To EBITDA | (2.92) | (2.78) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:Check out the analysis of Pacific Biosciences Correlation against competitors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. Anticipated expansion of Pacific directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pacific Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.10) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Understanding Pacific Biosciences requires distinguishing between market price and book value, where the latter reflects Pacific's accounting equity. The concept of intrinsic value - what Pacific Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Pacific Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Pacific Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pacific Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pacific Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.